Glutamine Sensitivity Analysis Identifies the xCT Antiporter as a Common Triple-Negative Breast Tumor Therapeutic Target
Luika Timmerman(University of California, San Francisco), Joe W. Gray(University of Newcastle Australia), Kornélia Polyák(Dana-Farber Cancer Institute), Anneleen Daemen, Thomas Holton(San Francisco State University), Mariia Yuneva(The Francis Crick Institute), Mercè Padró(UCSF Helen Diller Family Comprehensive Cancer Center), Raymond J. Louie(Greenwood Genetic Center), Stephen P. Ethier(Medical University of South Carolina), Frank McCormick(Frederick National Laboratory for Cancer Research), Min Hu(Novartis (China)), Denise A. Chan(University of California, San Francisco), Laura van ‘t Veer
Cited by 571
Related Papers
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
|New England Journal of Medicine|2002|6.5k
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
|Nature reviews. Cancer|2009|3.3k
The Genomic Landscapes of Human Breast and Colorectal Cancers
|Science|2007|2.8k